HIGHLIGHTS
- who: Shouyi Wei from the United States United States United States have published the research: Dose rate and dose robustness for proton transmission FLASH-RT treatment in lung cancer, in the Journal: (JOURNAL)
- what: The work has demonstrated the dosimetric advantages of clinical IMPT plans over transmission plans, with superior OAR doses, comparable target uniformity, and slightly inferior plan robustness in target coverage.
- how: Patient #1 has a tumor located on the right mid lung and the results are shown in Figures 1A-D and the 2D dose distributions for different types of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.